KANTAR HEALTH BLOG
Brand and Customer Experience
Marketing Insights / Consultancy
Oncology Conference Insight
The "Science" and "Art" behind a Great Segmentation Study
Patient Blog Studies Tell Full Story of Disease Impact
Revitalizing the Market Research Survey to Improve Response Rate
World Cancer Day: we can, I can!
Opdivo Making Strides in Advanced Hepatocellular Carcinoma
Healthcare Chatbots: The Physician's Assistant of the Future?
by Brian Mondry | Nov 28, 2016
A lack of engagement after the patient leaves a doctor’s office or hospital contributes to higher costs and worse health outcomes. The easier we make it for patients to engage with their health the more likely they are to do so in a way that will make an actual difference.
Reach out to patients - we don't bite
by Lynnette Cooke | Nov 18, 2016
The gaps between patients, pharma, researchers and physicians offer an opportunity for the industry to step up and provide reliable, relatable information to empower consumers.
It’s lobbying, Jim, but not as we know it
by Mark Sales | Nov 16, 2016
Reputation is something that has always been close to our hearts in healthcare, an industry often derided by many (including my non-pharma friends) as “evil,” yet the numbers tell a different story.
Integrated Delivery Networks’ Emerging Influence on Cancer Care
by Debbie Warner | Nov 16, 2016
Market forces continue to drive oncology practices to align, invest and adapt to capture patient volume, adjust to decreasing payer reimbursement, optimize revenue, and reduce financial risk.
Movember: Information against prejudice
by Otávio Clark | Nov 14, 2016
In Brazil, prostate cancer is the second most common type of cancer among men (second only to non-melanoma skin cancer), according to the National Cancer Institute José Alencar Gomes da Silva (INCA).
Terms & Conditions
© 2017 Kantar Health, A Kantar Company